Beta2-adrenergic receptor genotype influences the effect of nonselective vs. selective beta-blockade on baroreflex function in chronic heart failure

International Journal of Cardiology

Volumn 153, Issue 2, 2011, Pages 230-232

  Truijen, Jasper ^a   De Peuter, Olav R ^a   Kim, Yu Sok ^a   Van Den Bogaard, Bas ^a   Kok, Wouter E ^a   Kamphuisen, Pieter W ^a   Van Lieshout, Johannes J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Autonomic function; Beta adrenergic receptors; Beta blockers; Heart failure; Pharmacogenetics

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARVEDILOL; GLUTAMIC ACID; GLYCINE; ISOPRENALINE; METOPROLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; SELOKEEN ZOC; UNCLASSIFIED DRUG; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;

DRUG ACTIVITY; DRUG DOSE TITRATION; DRUG EFFICACY; GENOTYPE; HAPLOTYPE; HEART FAILURE; HOMOZYGOSITY; HUMAN; LETTER; MORTALITY; PATIENT COMPLIANCE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SURVIVAL; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; AGED; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; AGED; BAROREFLEX; CHRONIC DISEASE; FEMALE; GENOTYPE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, BETA-2;

EID: 81755173499     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.052     Document Type: Article

References (27)

1. E.R. Azevedo, T. Kubo, and S. Mak Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure: differential effects on sympathetic activity Circulation 104 2001 2194 2199
2. L.W. Bogert, K.H. Wesseling, and O. Schraa Pulse contour cardiac output derived from non-invasive arterial pressure in cardiovascular disease Anaesthesia 65 2010 1119 1125
3. J.M. Brophy, L. Joseph, and J.L. Rouleau Beta-blockers in congestive heart failure. A Bayesian meta-analysis Ann Intern Med 134 2001 550 560
4. P. de Groote, N. Lamblin, and N. Helbecque The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure Eur J Heart Fail 7 2005 966 973
5. J.C. Dewar, A.P. Wheatley, A. Venn, J.F. Morrison, J. Britton, and I.P. Hall Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population Clin Exp Allergy 28 1998 442 448
6. V. Dishy, G.G. Sofowora, and H.G. Xie The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization N Engl J Med 345 2001 1030 1035
7. S.A. Green, J. Turki, M. Innis, and S.B. Liggett Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 1994 9414 9419
8. A. Hjalmarson, and F. Waagstein COMET: a proposed mechanism of action to explain the results and concerns about dose Lancet 362 2003 1077 1078
9. A. Kardos, G. Watterich, R. de Menezes, M. Csanady, B. Casadei, and L. Rudas Determinants of spontaneous baroreflex sensitivity in a healthy working population Hypertension 37 2001 911 916
10. D.M. Kaye, B. Smirk, C. Williams, G. Jennings, M. Esler, and D. Holst Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure Pharmacogenetics 13 2003 379 382
11. T. Kubo, J.D. Parker, and E.R. Azevedo Vagal heart rate responses to chronic beta-blockade in human heart failure relate to cardiac norepinephrine spillover Eur J Heart Fail 7 2005 878 881
12. M.T. La Rovere, G.D. Pinna, and R. Maestri Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era J Am Coll Cardiol 53 2009 193 199
13. D.E. Lanfear, P.G. Jones, S. Marsh, S. Cresci, H.L. McLeod, and J.A. Spertus Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome JAMA 294 2005 1526 1533
14. D. Lucini, M. Pagani, G.S. Mela, and A. Malliani Sympathetic restraint of baroreflex control of heart period in normotensive and hypertensive subjects Clin Sci (Lond) 86 1994 547 556
15. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, and P.W. Armstrong Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
16. MERIT-HF study group Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
17. M. Metra, L. Covolo, and N. Pezzali Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure Cardiovasc Drugs Ther 24 2010 49 60
18. L. Mircoli, L. Fedele, and M. Benetti Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure Circulation 106 2002 866 872
19. A. Mortara, M.T. La Rovere, G.D. Pinna, R. Maestri, S. Capomolla, and F. Cobelli Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure J Am Coll Cardiol 36 2000 1612 1618
20. A. Mortara, M.T. La Rovere, and G.D. Pinna Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications Circulation 96 1997 3450 3458
21. M. Packer, M.R. Bristow, and J.N. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
22. P.A. Poole-Wilson, K. Swedberg, and J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
23. A.J. Sehnert, S.E. Daniels, and M. Elashoff Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol J Am Coll Cardiol 52 2008 644 651
24. L.G. Shewan, and A.J.S. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
25. J. Shin, M.T. Lobmeyer, and Y. Gong Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure Am J Cardiol 99 2007 250 255
26. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) Eur Heart J 26 2005 1115 1140
27. B.E. Westerhof, J. Gisolf, W.J. Stok, K.H. Wesseling, and J.M. Karemaker Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set J Hypertens 22 2004 1371 1380